Guardion Health Sciences, Inc. Common Stock
GHSI
GHSI was delisted on the 11th of October, 2024.
12 hedge funds and large institutions have $595K invested in Guardion Health Sciences, Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 3 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
69% more capital invested
Capital invested by funds: $351K → $595K (+$244K)
9% more funds holding
Funds holding: 11 → 12 (+1)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$8.65K |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$7 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$4.87K |
| 2 |
Renaissance Technologies
New York
|
-$1.48K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1.03K |
| 4 |
S
SignatureFD
Atlanta,
Georgia
|
-$107 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $341K | -$1.48K | -200 | -0.5% |
|
2
Vanguard Group
Malvern,
Pennsylvania
| $134K | – | – | – |
|
3
BlackRock
New York
| $90.5K | – | – | – |
|
|
4
UBS Group
Zurich,
Switzerland
| $10.6K | +$8.65K | +1,172 | New |
|
|
TRCT
5
Tower Research Capital (TRC)
New York
| $9.01K | -$1.03K | -140 | -12% |
|
|
6
Morgan Stanley
New York
| $5.95K | -$4.87K | -659 | -50% |
|
7
Citigroup
New York
| $3.37K | – | – | – |
|
|
CPG
8
Cornerstone Planning Group
Fairfield,
New Jersey
| $296 | – | – | – |
|
|
FDCDDQ
9
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $153 | – | – | – |
|
10
Wells Fargo
San Francisco,
California
| $81 | – | – | – |
|
11
Osaic Holdings
Scottsdale,
Arizona
| $54 | – | – | – |
|
|
12
Fidelity Investments
Boston,
Massachusetts
| $9 | +$7 | +1 | New |
|
|
S
13
SignatureFD
Atlanta,
Georgia
| – | -$107 | -20 | Closed |
|
GHSI Hedge Fund Activity: Q1 2024 in Review
12 of the 6,945 institutional investors tracked by Wall St. Rank reported a position in Guardion Health Sciences, Inc. Common Stock (GHSI) for Q1 2024, worth a combined $595K — up 69% from $351K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new GHSI positions and 1 closed out — a net gain of 1 holder — while 0 added to existing stakes and 3 trimmed.
The largest buyer was UBS Group, opening a new position worth an estimated $8.65K. The largest seller was Morgan Stanley, cutting an estimated $4.87K.
- 12 institutional investors held Guardion Health Sciences, Inc. Common Stock (GHSI) as of Q1 2024, up from 11 in Q4 2023.
- Funds reported $595K of Guardion Health Sciences, Inc. Common Stock stock for Q1 2024, up 69% quarter-over-quarter.
- 2 funds opened new Guardion Health Sciences, Inc. Common Stock positions in Q1 2024 and 1 closed out, a net change of +1 holder.
- The largest Guardion Health Sciences, Inc. Common Stock buyer in Q1 2024 was UBS Group, an estimated $8.65K added.
- The largest Guardion Health Sciences, Inc. Common Stock seller in Q1 2024 was Morgan Stanley, an estimated $4.87K sold.
Based on aggregated 13F filings for Q1 2024.